Martinez, GA, United States of America

Jin-Xiong She

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.2

ph-index = 1


Company Filing History:


Years Active: 2006-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jin-Xiong She

Introduction

Jin-Xiong She is a prominent inventor based in Martinez, GA, known for his significant contributions to the field of biomedical research. With a total of four patents to his name, he has made notable advancements in the diagnosis and treatment of hematological malignancies and Type 1 diabetes.

Latest Patents

One of his latest patents is focused on Stat5b transgenic mice and methods of use thereof. This invention has revealed that STAT5 phosphorylation and CD150 serve as effective biomarkers for detecting, diagnosing, and monitoring hematological malignancies, including lymphomas. Additionally, he has developed compositions and methods for identifying therapeutic agents for treating these malignancies using p-STAT5, CD150, or both as biomarkers. Another significant patent involves antibodies against SUMO4 polypeptides. These antibodies are selectively directed against SUMO4 polypeptides and are valuable as research tools, further aiding in the diagnosis and treatment of Type 1 diabetes.

Career Highlights

Throughout his career, Jin-Xiong She has worked with esteemed institutions such as the Medical College of Georgia Research Institute and Georgia Regents Research Institute. His work has been instrumental in advancing research in his field and has contributed to the development of innovative therapeutic strategies.

Collaborations

He has collaborated with notable colleagues, including Cong-Yi Wang and Bo Chen, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Jin-Xiong She’s contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the diagnosis and treatment of critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…